Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study - Concepedia

Concepedia

Publication | Closed Access

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

343

Citations

8

References

2009

Year

Quan Dong Nguyen, Syed Mahmood Shah, Jeffrey S. Heier, V. Diana, Jennifer I. Lim, David S. Boyer, Prema Abraham, Peter A. Campochiaro

Metabolic SyndromeDiabetes ManagementSix MonthsInsulin ManagementDiabetesPrimary End PointDiabetes MellitusMedicine

References

	Year	Citations

Page 1